Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-003676-22Phase 3Completed
Phase 3, randomised trial in Acute Heart Failure (AHF) comparing Clevidipine IV infusion with Standard-of-care IV antihypertensive (2 arms). Primary endpoints: Time to attainment of initial prespecified systolic blood pressure target range and Proportion attaining blood pressure target and 15% systolic blood pressure reduction. Started Jan 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-003676-22.